Union Budget 2026: Govt to overhaul drug regulator CDSCO, announces Rs 10,000 crore ‘Biopharma Shakti’ push

India Budget 2026: India's drug regulatory authority, CDSCO, will be strengthened to meet global standards and speed up approvals. A new initiative, Biopharma Shakti, with a Rs 10,000 crore outlay over five years, will boost domestic production of biologics and biosimilars. This strategy includes establishing 1,000 accredited clinical trial sites and upgrading NIPERs.